Two-way SMS support for newborn care with community health volunteers in Western Kenya
Official title: CHV-NEO: Community-based Digital Communication to Support Neonatal Health
Run by University of Washington · NCT05187897 · Data updated 2026-11-12
This project will test whether daily automated and interactive SMS messages linking new mothers to community health volunteers can help mothers spot newborn danger signs and get timely help in Western Kenya.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years and up |
| Sex | Women only |
| Enrollment | 3000 (estimated) |
| Sponsor | University of Washington Academic / other |
| Locations | 1 site (Kisumu) |
| Status | Recruiting |
| Started | January 10, 2024 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | December 11, 2025 |
| Trial ID | NCT05187897 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women 26–36 weeks gestation who have daily access to a mobile phone (own or shared), are willing to receive and respond to SMS in English, Kiswahili, or Luo (or have household help), are aged 14 or older, receive antenatal care at a participating facility, and plan to remain in the area for at least three months postpartum.
✕Probably not a fit
People without reliable phone access, those unwilling or unable to receive/read SMS and without someone to help, or those already enrolled in a conflicting study are unlikely to benefit from this SMS-based intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This cluster-randomized trial integrates an interactive SMS program (Mobile WACh Neo) into the existing digital community health toolkit used by Community Health Volunteers (CHVs) in Western Kenya. Enrolled pregnant women receive daily, theory-based messages after delivery that guide recognition of neonatal danger signs and enable real-time texting with a health worker for triage and support. The intervention is delivered alongside routine CHV home visits and is intended to augment CHV workflow rather than replace in-person care. Outcomes focus on timely care-seeking, neonatal health events, and feasibility of embedding SMS communication into CHV digital systems.
Why it matters
Potential benefit: If successful, this could help mothers identify newborn danger signs earlier and obtain faster guidance and referrals, potentially reducing neonatal deaths.
How similar studies have gone: Related two-way SMS programs (including prior Mobile WACh work) have shown promise for maternal and newborn communication and care engagement, though integrating such systems directly into CHV digital workflows is a newer approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant * 26-36 weeks gestation * Daily access to a mobile phone (own or shared) * Willing to receive SMS * Age ≥14 years * Able to read and respond to text messages in English, Kiswahili or Luo, or have someone in the household who can help * Receiving antenatal care at study facility * Plan to be in the area for at least 3 months postpartum Exclusion Criteria: * participating in another study * previously participated in this study
Where it's running
-
Kenyatta National Hospital
Kisumu, Kenya Recruiting
Study contacts
- Principal investigator: Keshet Ronen, MPH, PhD — University of Washington
- Study coordinator: Lincoln Pothan
- Email: lpothan@uw.edu
- Phone: +1-206-685-4363
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Amnioinfusion to Protect Newborns After Meconium in Amniotic Fluid
This trial tests whether a structured lactated Ringer's amnioinfusion during labor can reduce breathing problems and related complications in babies whose amniotic fluid contains meconium.
-
Improving intrapartum care in Ethiopia to reduce stillbirths and maternal deaths
This study is testing a new approach to improve care during childbirth in Ethiopia to see if it can help reduce stillbirths and keep mothers safer.
-
Identifying factors to prevent early stillbirths
This study is trying to find out what changes can be made in behavior and healthcare to help prevent stillbirths that happen between 20 and 28 weeks of pregnancy.
-
Screening and planned delivery to prevent preeclampsia at term
This study is testing a new blood test to see if it can help predict preeclampsia in first-time pregnant women and if inducing labor early can lower the chances of complications for both mom and baby.
-
Using aspirin to prevent complications in pregnant women with chronic hypertension
This study is testing whether taking low-dose aspirin during pregnancy can help prevent serious complications for women with chronic high blood pressure and their babies.
-
Using ultrasound to improve detection of fetal growth issues
This study is trying to see if using ultrasound in a structured way can help doctors better spot babies that are not growing properly during pregnancy to reduce the risk of stillbirth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.